Sentences with phrase «civ h3n8»

Disease caused by CIV H3N2 may be slightly more severe than that caused by CIV H3N8, and the virus has affected more dogs in veterinary hospitals and the community (H3N8 has largely remained confined to shelters).

Symptoms of Canine Influenza H3N2 are similar to those of CIV H3N8.

For the past several years, vaccines, including Zoetis Vanguard ® CIV (H3N8), have been used to help control disease associated with CIV H3N8.

About Canine Influenza There are two prevalent types of canine influenza virus in the United States: CIV H3N8 and now, CIV H3N2.

Dogs with CIV H3N2 may show more severe signs than dogs with CIV H3N8 and in less than 10 % of cases can be fatal.

Because most dogs have not been exposed to Dog Flu (CIV H3N8 and CIV H3N2), almost 100 % of those exposed are fully susceptible.

According to clinical studies by researchers at the University of Wisconsin, the CIV H3N2 may be shed for an extended period of time — up to 24 days, which is far longer than what is seen with CIV H3N8.2 As a result, the infection can spread quickly among social dogs in inner cities, doggie daycares, boarding facilities, dog parks, sporting and show events and any location where dogs commingle.

CIV H3N8 was first diagnosed in 2004 and has impacted dogs in more than 40 states.

«There is no way to predict whether it will be CIV H3N2 or CIV H3N8 that infects your area, so it is better to help protect against both strains,» said Dr. Carey, speaking on behalf of Zoetis.

Canine influenza virus (CIV H3N8) has been confirmed in dogs across 43 states and the District of Columbia.

Influenza A, or Canine Influenza Virus (CIV H3N8), was first identified in racing greyhounds in Florida in 2004.

Vanguard CIV H3N8 vaccine is licensed for use in healthy dogs 8 weeks of age or older.

The Vanguard CIV H3N8 vaccine is part of the Zoetis family of CIRD vaccines.

Vaccines against Dog Flu (CIV H3N8 and CIV H3N2) are available through your veterinarian.

The signs of Dog Flu (CIV H3N8 and CIV H3N2) infections can be hard to tell from canine cough.

The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S., CIV H3N2 and CIV H3N8.

* «There is no way to predict whether it will be CIV H3N2 or CIV H3N8 that infects your area, so it is better to help protect against both strains; this bivalent vaccine allows you do to that efficiently.»

Chances are, if your dog is exposed to CIV H3N2 or CIV H3N8, he or she may become infected.

Notably, immunogenicity and protection efficacy conferred by the NS1 mutant H3N8 CIVs was better than that observed with a CIV H3N8 inactivated influenza vaccine (IIV).

All recombinant NS1 mutant viruses were attenuated in vivo (mice) and ex vivo (canine tracheal explants), but able to confer, upon a single intranasal immunization dose, complete protection against challenge with WT CIV H3N8.

All vaccinates had detectable titers to CIV H3N2 and CIV H3N8 by day 21 when the second vaccination was administered.

Not exact matches

VIP Petcare has vaccines available to help control diseases associated with CIV H3N2 and H3N8.

The first US strain of canine influenza virus (CIV), H3N8, was identified in racing greyhounds in Florida in January 2004.

Introducing VANGUARD ® CIV H3N2 / H3N8, a bivalent canine flu vaccine with demonstrated safety and efficacy for protection against both highly contagious H3N2 and H3N8 strains of canine influenza virus (CIV).

0 % of dogs vaccinated with VANGUARD CIV H3N2 / H3N8 had evidence of CIV H3N2 infection on a microscopic exam of lungs and trachea

Dogs vaccinated with VANGUARD CIV H3N2 / H3N8 shed virus for an average of 1.3 days after challenge.

Twenty dogs were vaccinated with VANGUARD CIV H3N2 / H3N8 on study days 0 and 21, and 20 dogs were placebo vaccinated on the same days.

The good news is that VIP Petcare now has vaccines available to help control disease associated with CIV H3N2 and H3N8.

This is the first description of a LAIV generated by reverse genetics for the prevention and control of H3N8 CIV in dogs.

CIV (canine influenza virus) H3N8: Annual booster after initial 2 - part vaccination * CIV (canine influenza virus) H3N2: Annual booster after initial 2 - part vaccination * * The first vaccine but be given at least 10 days prior to an arrival at Rover Oaks Pet Resort

Non-structural protein 1 (NS1) truncated (NS1 - 126, NS1 - 99 and NS1 - 73) or deleted (DNS1) H3N8 canine influenza viruses (CIVs) were tested for their safety, immunogenicity and protection efficacy as live - attenuated influenza vaccines (LAIVs) against wild - type (WT) H3N8 CIV.

The safety of the Vanguard CIV H3N2 / H3N8 vaccine was demonstrated in a study involving 364 dogs, including 164 client - owned dogs and 200 dogs from commercial breeding facilities.

In a pivotal efficacy study, dogs receiving the Vanguard CIV H3N2 / H3N8 vaccine were protected from disease after CIV H3N2 challenge.2, 3,4 Vaccination also appeared to help decrease the number of days after challenge that dogs shed CIV H3N2 virus — from an average of 4.9 days in the placebo - vaccinated controls to an average of 1.3 days in Vanguard CIV H3N2 / H3N8 vaccinates.2, 5,6

There are currently two canine influenza virus (CIV) strains affecting dogs in the U.S., H3N8 and H3N2.

PARSIPPANY, N.J. — Dec. 12, 2017 — Zoetis today announced the launch of Vanguard ® CIV H3N2 / H3N8, the latest vaccine in the company's canine influenza virus (CIV) portfolio.

To learn more about Vanguard CIV H3N2 / H3N8, visit www.vanguardciv.com.

There are currently two pharmaceutical manufacturers that offer CIV vaccines for the H3N8 and H3N2 strains.

Typically, CIRD is treated with supportive care and antibiotics when appropriate.6 According to the American Veterinary Medical Association (AVMA), dogs that are frequently in social situations with other dogs — such as in boarding facilities or day care — can be at especially high risk of infection with CIRD.7 Zoetis offers a broad range of flexible solutions, including Bronchicine ® CAe (injectable); Vanguard ® Plus 5; Vanguard ® CIV (H3N8); the new Canine Influenza Vaccine, H3N2, Killed Virus; and now, Vanguard ® Rapid Resp Intranasal and Vanguard ® B Oral vaccines.

The two known CIVs are H3N8 and H3N2.

The dog flu, or Canine Influenza Virus (CIV H3N2 or H3N8), is a highly contagious infection caused by an influenza virus and is transmitted by aerosolized respiratory secretions — think coughing and sneezing.

There are actually two forms of CIV, the H3N8 strain, which has been around since at least 2005, and the H3N2 strain, which was first reported outside of Asia in 2015.

We are strongly recommending to vaccinate against Canine Flu for all dogs: Canine Influenza Virus H3N2 / H3N8 (CIV).

CANINE INFLUENZA VIRUS H3N2 / H3N8 (CIV) starting at 8 weeks of age, then again 3 to 4 weeks later.

Vanguard ® CIV H3N2 / H3N8 is a canine flu vaccine that protects against both strains of the canine influenza virus.

Please consult your veterinarian regarding the CANINE INFLUENZA VIRUS H3N2 / H3N8 (CIV) series of vaccinations.

Zoetis Inc. has started shipping Vanguard CIV H3N2 / H3N8, the company's newest vaccine against canine influenza virus.

VSC's Canine Influenza Protocol There has been a lot of media attention about the Canine Influenza Virus (CIV or H3N8) outbreak in the Chicago area in recent weeks.

There has been a lot of media attention about the Canine Influenza Virus (CIV or H3N8) outbreak in the Chicago area in recent weeks.

MADISON, N.J. --(BUSINESS WIRE)-- Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today announced that the U.S. Department of Agriculture has approved a license for Nobivac ® Canine Flu Bivalent vaccine — the first vaccine to aid in the control of disease associated with both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8.

Zoetis provides the Vanguard CIV H3N2 / H3N8 vaccine for protection against both highly contagious strains of CIV.